SCHEMBL25495338

SCHEMBL25495338

Cc1ccccc1S(=O)(=O)Nc1ccc(Br)c(C)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 6/20 0.62
EDNRB P24530 3/20 0.53
ALDH1A1 P00352 4/20 0.51
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
MAPK1 P28482 1/20 0.51
RXFP1 Q9HBX9 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TP53 P04637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SLC40A1 Q9NP59 1/20 0.46
PKM P14618 2/20 0.44
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
HSD11B1 P28845 1/20 0.42
HSPD1 P10809 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN5 P54829 1/20 0.41
HSPE1 P61604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30634082 0.86 EDNRA (0.60) EDNRAEDNRBALDH1A1RAB9ANPC1
SCHEMBL21048025 0.86 EDNRA (0.60) EDNRAEDNRBALDH1A1RAB9ANPC1
SCHEMBL21047981 0.86 PKM (0.60) EDNRAEDNRBALDH1A1RAB9ANPC1
SCHEMBL30634104 0.86 PKM (0.60) EDNRAEDNRBALDH1A1RAB9ANPC1
SCHEMBL7768351 0.85 EDNRA (0.72) EDNRAEDNRBALDH1A1MAPK1PKM
SCHEMBL20575792 0.83 EDNRA (0.46) EDNRAEDNRBALDH1A1MAPK1RXFP1
SCHEMBL30634072 0.83 EDNRA (0.46) EDNRAEDNRBALDH1A1MAPK1RXFP1
SCHEMBL20575653 0.82 KDM4E (0.60) EDNRAEDNRBALDH1A1RAB9ANPC1
SCHEMBL21048001 0.79 EDNRA (0.58) EDNRAEDNRBL3MBTL1SLC40A1PKM
SCHEMBL30634105 0.79 EDNRA (0.58) EDNRAEDNRBL3MBTL1SLC40A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11649224-B2 IRE1 small molecule inhibitors CORNELL UNIVERSITY (US) 2023-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11649224-B2 IRE1 small molecule inhibitors XBP1, ERN2, ERN1 EDNRA 2093/4885EDNRB 2191/4885ALDH1A1 3482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.